Alex Knapp, Forbes Staff

Author's posts

InnovationRx: Venture Capital For Digital Health Is Down; Plus, The New Omicron Variant

InnovationRx is your weekly digest of healthcare news. Sign up!

Pfizer Signs Deal With UNICEF To Distribute Its Covid Antiviral Drug

The pharmaceutical giant will provide 4 million courses of Paxlovid to 95 low- and middle-income countries.

Covid Year 3 Will Be Better, Experts Agree, Unless Rich Countries Ignore The Pandemic Elsewhere

The worst of the pandemic is behind us, experts told Forbes, in part because the first two years provided valuable tools for the continued fight against both Covid and future disease epidemics.

Pfizer’s Started Clinical Trials For Its Covid Antiviral In Kids

The company’s antiviral pill, Paxlovid, is currently authorized for high-risk patients aged 12 and up. This study will look at kids above age 6.

Moderna Aims To Make Vaccines Against 15 Deadly Diseases—And The Next Pandemic

The company’s new public health initiative aims to work with middle- and low-income countries to combat diseases, while working with scientists worldwide to develop vaccines for the next potentially deadly outbreak.

Novavax Reports Enduring Covid Immune Response Six Months After Vaccination

The company’s protein-based vaccine showed strong efficacy over time, and it reported $1.1 billion in revenue in 2021.

Covid-19 Stalks The Battlefields Of Ukraine

Less than 35% of the country’s population is fully vaccinated, and Covid-19 treatments will be harder to access in the middle of a war zone.

Benchling Expands Its Science Software Capabilities With Its First Acquisition

The cloud-based lab software company will be acquiring Belfast-based Overwatch Research, which has developed software geared towards in vivo research.

Billionaire Jared Isaacman Plans To Go Back To Space This Year

Last September, billionaire Jared Isaacman made space history with his Inspiration4 flight.

Doctors Successfully Transplanted A Gene-Edited Pig Kidney – And They Have Plans To Scale Up

The successful transplantation by scientists at University of Alabama-Birmingham into a brain-dead human body paves the way to clinical trials — and hope for thousands of patients suffering kidney disease.